Narges Alipanah-Lechner
San Francisco, United States
Narges Alipanah-Lechner, MD, MAS, is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine at UCSF. She received her undergraduate degree from Johns Hopkins University and her medical degree and master’s degree in clinical and epidemiological research from UCSF. Dr. Alipanah-Lechner’s research interest is to apply complementary systems biology approaches within precision medicine to improve the diagnosis and treatment of patients with syndromes of critical illness. Her post-doctoral fellowship in the laboratories of Drs. Calfee and Matthay led to the discovery of novel subtypes of severe COVID-19 pneumonia as well as metabolic differences amongst patients with phenotypes of ARDS. She leads the biology committee of the first international platform trial utilizing precision medicine in ARDS and was awarded the American Society for Clinical Investigation’s 2024 Emerging Generation Award. In addition to her research endeavors, she attends in the medical and neurological intensive care units at UCSF.
